Title: NeoPharm and LegoChem collaborate on novel anti-inflammary drug Publication: INEWS Date: June 21st, 2007 · On June 21st, NeoPharm and LegoChem announed their agreement on co-developing new PAR2 inhibitors.
· NeoPharm is investing $5 milion in LegoChem, acquiring 3.46% of the entire equity, and will receive degrees of royalty according to phases of following technology transfer. To view the full article (in Korean), http://news.inews24.com/php/news_view.php?g_serial=267965&g_menu=020400 |